Stock Research for KOOL

KOOL

Featured Broker: Ally Invest

Get the due diligence for another stock.

 

KOOL Stock Chart & Research Data

The KOOL chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the KOOL chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.


 


KOOL Due diligence Resources & Stock Charts

The KOOL stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.

The Four Most Popular Resources

CNN View KOOL Detailed Price Forecast - CNN Money CNN View KOOL Detailed Summary - Google Finance
Yahoo View KOOL Detailed Summary - Yahoo! Finance Zacks View KOOL Stock Research & Analysis - Zacks.com


Stock Analysis

TradeIdeas View KOOL Trends & Analysis - Trade-Ideas Barrons View KOOL Major Holders - Barrons
NASDAQ View KOOL Call Transcripts - NASDAQ Seeking View KOOL Breaking News & Analysis - Seeking Alpha
Spotlight View KOOL Annual Report - CompanySpotlight.com OTC Report View KOOL OTC Short Report - OTCShortReport.com
TradeKing View KOOL Fundamentals - TradeKing Charts View KOOL SEC Filings - Bar Chart
WSJ View Historical Prices for KOOL - The WSJ Morningstar View Performance/Total Return for KOOL - Morningstar
MarketWatch View the Analyst Estimates for KOOL - MarketWatch CNBC View the Earnings History for KOOL - CNBC
StockMarketWatch View the KOOL Earnings - StockMarketWatch MacroAxis View KOOL Buy or Sell Recommendations - MacroAxis
Bullish View the KOOL Bullish Patterns - American Bulls Short Pains View KOOL Short Pain Metrics - ShortPainBot.com


Social Media Mentions

StockTwits View KOOL Stock Mentions - StockTwits PennyStocks View KOOL Stock Mentions - PennyStockTweets
Twitter View KOOL Stock Mentions - Twitter Invest Hub View KOOL Investment Forum News - Investor Hub
Yahoo View KOOL Stock Mentions - Yahoo! Message Board Seeking Alpha View KOOL Stock Mentions - Seeking Alpha






Financial & Transaction Holdings

SECform4 View Insider Transactions for KOOL - SECform4.com Insider Cow View Insider Transactions for KOOL - Insider Cow
CNBC View KOOL Major Holdings Summary - CNBC OTC Markets View Insider Disclosure for KOOL - OTC Markets
Yahoo View Insider Transactions for KOOL - Yahoo! Finance NASDAQ View Institutional Holdings for KOOL - NASDAQ


Stock Charts

FinViz View KOOL Stock Insight & Charts - FinViz.com StockCharts View KOOL Investment Charts - StockCharts.com
BarChart View KOOL Stock Overview & Charts - BarChart Trading View View KOOL User Generated Charts - Trading View


Latest Financial News for KOOL

Cesca Therapeutics Announces Exhibition at The Orthobiologic Institute’s 9th Annual PRP & Regenerative Medicine Symposium
Posted on Wednesday June 06, 2018

Cesca Therapeutics Inc. (“Cesca” or the “Company”) (KOOL), a market leader in automated cell processing and point-of-care, autologous cell-based therapies, today announced that the Company will be exhibiting its development-stage PXP™ System at The Orthobiologic Institute’s (TOBI) 9th Annual PRP & Regenerative Medicine Symposium with Workshops & Cadaver Labs, which is being held June 7-9 in Las Vegas. “In a mini review recently published in the peer-reviewed Journal of Orthopedic Research and Therapy, we report on the role of various bone marrow derived cells and cytokines used in the treatment of different orthopedic indications, such as knee osteoarthritis,” said Dalip Sethi, Ph.D., Senior Director of Research and Development at Cesca.


Rancho Cordova-based Cesca Therapeutics cutting about 20 jobs
Posted on Monday June 04, 2018

Rancho Cordova-based medical technology company Cesca Therapeutics Inc. said it's cutting 25 percent of its workforce to reduce expenses.


Cesca Therapeutics Announces Reduction in Operating Expenses
Posted on Monday June 04, 2018

Cesca Therapeutics Inc. (“Cesca” or the “Company”) (KOOL), a market leader in automated cell processing and point-of-care, autologous cell-based therapies, today announced that it is reducing its US and India workforce by approximately 25%, to a total of 60 full-time equivalent employees, under a plan to be substantially completed by the end of June. This reduction is designed to lower operating expenses while the Company focuses on driving growth of revenue-generating products, while at the same time continuing to develop and commercialize the CAR-TXpress™ cellular processing platform and related X-Series™ products. “Focusing our efforts on the development and commercialization of CAR-TXpress, and increasing sales of our revenue-generating products, will best position the Company for long-term success,” said Chris Xu, chief executive officer of Cesca.


Cesca Therapeutics Inc’s (NASDAQ:KOOL) Profit Outlook
Posted on Thursday May 31, 2018

Cesca Therapeutics Inc’s (NASDAQ:KOOL): Cesca Therapeutics Inc. develops, commercializes, and markets a range of automated technologies and products for cell-based therapeutics in the United States, China, rest of Asia, Europe,Read More...


Enter a stock symbol to view the stock details.